Blogs

Understand antibody drug conjugate science, bioconjugation, and manufacturing controls that shape targeted therapy for cancer. Read the article today.

Tech transfer sounds like a handover, but in a CDMO, it is a stress test. A process that behaves in a bench hood can shift when it meets plant-scale mixing, utilities, sampling routines, and tighter execution windows.

Self-amplifying RNA (saRNA) is emerging as the next wave in mRNA-based therapeutics, building on the achievements of first-generation mRNA vaccines and treatments.

Green chemistry principles have moved from being a “nice to have” idea to a practical framework that shapes how molecules are discovered, developed and manufactured.

See how chemistry, biology, DMPK, and DMTA expertise with a trusted preclinical CRO make integrated drug discovery faster and more reliable. Read now.

Clear guidance on bispecific antibodies, from formats and engineering to analytics and control strategy, for scalable development and manufacturing. Read now.

Prove induced proximity in molecular glues with ITC, fluorescence polarization, and co-IP. Practical steps for stronger discovery decisions. Read the guide.

Explore how plasmid DNA, mRNA CDMO, and viral vector manufacturing are scaling to meet the rising demand of AAV gene therapy and genetic medicines. Read on to know more.

Customer-centric pharma project management software for CRDMO programs—integrating metrics, feedback, and risk on one platform to deliver with speed and quality.

Syngene’s translational research speeds drug discovery and development and enables personalized medicine with robust models and biomarkers. Explore the approach.